BAYER Aspirin Original, CVP HEALTH
- Product NDC
- 66715-6526
- 11-digit product format
- 667156526
- Labeler code
- 66715
- Product ID
- 66715-6526_27e5d448-9afb-9188-e063-6394a90a5fff
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ASPIRIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lil' Drug Store Products, Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-05-06
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BAYER Aspirin Original, CVP HEALTH
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66715-6526-2 | BAYER Aspirin Original, CVP HEALTH | 2 in 1 CARTON | TABLET | 2 | 8 | |
| 66715-6526-2 | BAYER Aspirin Original, CVP HEALTH | 2 in 1 POUCH | TABLET | 2 | 8 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | BAYER (ASPIRIN) TABLET [LIL' DRUG STORE PRODUCTS, INC.] | 1 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | BAYER (ASPIRIN) TABLET [LIL' DRUG STORE PRODUCTS, INC.] | 1 | |
| carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | BAYER (ASPIRIN) TABLET [LIL' DRUG STORE PRODUCTS, INC.] | 1 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | BAYER (ASPIRIN) TABLET [LIL' DRUG STORE PRODUCTS, INC.] | 1 | |
| powdered cellulose | INACTIVE INGREDIENT | SMD1X3XO9M | BAYER (ASPIRIN) TABLET [LIL' DRUG STORE PRODUCTS, INC.] | 1 | |
| starch, corn | INACTIVE INGREDIENT | O8232NY3SJ | BAYER (ASPIRIN) TABLET [LIL' DRUG STORE PRODUCTS, INC.] | 1 | |
| triacetin | INACTIVE INGREDIENT | XHX3C3X673 | BAYER (ASPIRIN) TABLET [LIL' DRUG STORE PRODUCTS, INC.] | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66715-6526 | BAYER (ASPIRIN) TABLET BAYER ASPIRIN ORIGINAL, CVP HEALTH (ASPIRIN) TABLET BAYER ASPIRIN ORIGINAL, TRAVEL BASIX (ASPIRIN) TABLET [LIL' DRUG STORE PRODUCTS, INC.] | 8 | Current NDC, 2 package rows | 20241215_7f5d9ebe-8119-49a2-9380-eca18a5e5e85.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dolex Children Pain and Fever | ACETAMINOPHEN | Pharmadel LLC | f9158463-aeb1-5de0-e053-6294a90a748b | 2024-03-04 | Warnings | M013 |
| SEDALMEX FORTE | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Belmora LLC | 33b3508e-4caa-4d05-9b15-cb82a2ee2d4d | 2024-02-28 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | AMERISOURCE BERGEN | 2b923a97-836c-4dac-a8c0-3047a35fb62e | 2024-02-23 | Warnings | M013 |
| Pain Reliever PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | BJWC (Berkley & Jensen / BJ's) | b20a08f3-c9c0-4bd9-8ce0-acb932b5bb86 | 2024-02-22 | Warnings | M013 |
| M-PAP | ACETAMINOPHEN | Bryant Ranch Prepack | 31a41976-7f65-42d7-acf5-de9c2c5ca58e | 2024-02-20 | Warnings | M013 |
| Publix Fast Relief Effervescent - Original Flavor | ASPIRIN | PUBLIX SUPER MARKETS INC. | 0a342f72-45fd-3e12-e063-6394a90ae33e | 2024-02-16 | Warnings | M013 |
| Equaline Effervescent Pain Reliever | ASPIRIN | UNITED NATURAL FOODS, INC. DBA UNFI | 0761299a-e913-7665-e063-6394a90a6003 | 2024-02-16 | Warnings | M013 |
| TopCare Effervescent Pain Relief | ASPIRIN | TOPCO ASSOCIATES LLC | 075f36e1-110c-e839-e063-6294a90a89d7 | 2024-02-16 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN | INGLES MARKETS, INC. | 115d0b4f-6f0f-79a9-e063-6394a90ab18a | 2024-02-14 | Warnings | M013 |
| PANADOL | ACETAMINOPHEN | Haleon US Holdings LLC | e1799765-c247-42b4-ad6a-8ba7d136abf2 | 2024-02-06 | Warnings | M013 |
| Panadol Cold and Flu NonDrowsy | ACETAMINOPHEN AND PHENYLEPRINE HCL | Haleon US Holdings LLC | f626ab17-01c9-4493-ba9e-0c8c11146384 | 2024-02-06 | Warnings | M013 |
| PANADOL Extra | ACETAMINOPHEN AND CAFFEINE | Haleon US Holdings LLC | e5c2d88a-d903-4ca0-b895-f27e791dfc4e | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | b2fe7f47-1a2e-40ee-8f8f-38f2028dce1b | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | 9d384e88-5c11-4600-ac6c-a38371570138 | 2024-02-06 | Warnings | M013 |
| PANADOL | ACETAMINOPHEN | Haleon US Holdings LLC | 95801755-db54-4ad7-bec1-52671914f6ca | 2024-02-06 | Warnings | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | 01e7dddb-755c-4745-b701-edcdb6209064 | 2024-02-06 | Warnings, Adverse reactions | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | fe7cd1f2-9b00-4ded-99c2-8a152c71093c | 2024-02-06 | Warnings, Adverse reactions | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | AptaPharma Inc. | 9064943f-836f-4853-b6f2-2c4879941eeb | 2024-02-02 | Warnings | M013 |
| Quality Choice Effervescent Pain Relief | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 079af5d7-1be8-2a93-e063-6294a90a496d | 2024-02-01 | Warnings | M013 |
| MEDI-FIRST Non-Aspirin | ACETAMINOPHEN | Proficient Rx LP | 4c84948d-3a95-4c53-8529-7e7b9d8bb6df | 2024-02-01 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 212033 | aspirin 325 MG Oral Tablet | PSN | 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 | 8 |
| 211874 | BAYER Aspirin 325 MG Oral Tablet | PSN | 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 | 8 |
| 211874 | aspirin 325 MG Oral Tablet [Bayer Aspirin] | SBD | 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 | 8 |
| 212033 | aspirin 325 MG Oral Tablet | SCD | 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 | 8 |
| 212033 | ASA 325 MG Oral Tablet | SY | 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 | 8 |
| 211874 | ASA 325 MG Oral Tablet [Bayer Aspirin] | SY | 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 | 8 |
| 211874 | Bayer Aspirin 325 MG Oral Tablet | SY | 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 66715-6526-2 | 66715652602 | 2 POUCH in 1 CARTON (66715-6526-2) / 2 TABLET in 1 POUCH | 2 pouch | 2022-05-06 | No | No | Current |